Pfizer to sell Schneider angio unit
Pharmaceutical company Pfizer of New York City announced last month that it is exploring alternatives for its Medical Technology Group that could include the divestiture of the business as a whole or in parts. The division includes Pfizer's Schneider
Pharmaceutical company Pfizer of New York City announced last month that it is exploring alternatives for its Medical Technology Group that could include the divestiture of the business as a whole or in parts. The division includes Pfizer's Schneider Worldwide business, which develops interventional radiology and cardiology products such as angioplasty balloon catheters. Other units in the business include Howmedica, which develops orthopedic devices, and American Medical Systems, a developer of urological implants. Pfizer was active in the medical imaging market in the 1980s, marketing such technologies as CT and mammography, but eventually exited the business.